Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200061778Phase 4Recruiting
Phase 4, randomised trial of ropivacaine, betamethasone and lidocaine in postoperative pain, anxiety disorder and postoperative depression (3 arms), sponsored by Affiliated Huai'an Hospital of Xuzhou Medical University. Primary endpoints: Quality of recovery-40 scale, Self-Rating Anxiety Scale and 2 more. Started Jul 2022; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200061778.